Board of Directors

Chair of the Board of Directors
Wei Zhang, PhD, Hanes and Willis Family Professor in Cancer, Director, Cancer Genomics and Precision Medicine, Wake Forest Baptist Comprehensive Cancer Center


Board of Directors (in alphabetic order)
Jin Gu, MD, (2009-present), Professor & Vice President of BeijingCancerHospital, School of Oncology, PekingUniversity, President-elect of Chinese Medical Association (CMA), Cancer Beijing, China
David H. Johnson, MD, (2009-present), Professor of Medicine, Director, Division of Hematology/Oncology, Deputy Director, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA
Wei Zhang, PhD (2009-present), Professor of Pathology and Cancer Biology, Director, Cancer Genomics Core Laboratory, The University of TexasM.D. Anderson Cancer Center, Houston, Texas, USA
Xishan Hao, MD (2009-present), President of Tianjin Medical University, President of Tianjin Cancer Research Institute & Hospital, President of Chinese Anti-Cancer Association (CACA), Tianjin, China
Joyce O Shaughnessy, M.D. (2009-present), Program Director for the School of Breast Oncology, Baylor-Sammons Cancer Center, Dallas, Texas, USA
Ex officio members of the Board
President (2013-2016)
Shiyuan Chen, Professor, Northwestern University Feinberg School of Medicine, Ken & Ruth Davee Department of Neurology, & Northwestern Brain Tumor Institute, Center for Genetic Medicine, The Robert H. Lurie Comprehensive Cancer Center
Managing Director
Li Yan, MD, PhD, Associate Director, Clinical Oncology, Merck & Co. Inc. , Adjunct Professor, School of Oncology, PekingUniversity
General Secretary
Yunguang Tong, PhD, Assistant Professor, Cedars-Sinai MedicalCenter, David Geffen School of Medicine, UCLA
Treasurer
Weimin Qi, MD, PhD, Director of Antibody Development, Biocare Medical, LLC.